Spectral AI Unites the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month

Spectral AI, Inc.(‘Spectral AI' or the 'Company'), an artificial intelligence (AI) company emphasized medical diagnostics for rapid & more accurate treatment decisions in wound care, is aligning with the American Board of Wound Management (ABWM) Foundation to celebrate the 10th Annual Wound Healing Awareness Month.

Vincent Capone, Chief Executive Officer of Spectral AI, commented that Wound Healing Awareness Month is a significant step, as patients living with painful, certain complex burn wounds necessitate a timely, accurate diagnosis & a personalised treatment approach.

About the American Board of Wound Management

The ABWM Foundation is a 501(c)(3) not-for-profit foundation that assists the work of the American Board of Wound Management (ABWM) for the progression of wound care, the advancement of certification for providers of chronic & acute wounds. Also, it facilitates the benefit of the public by emerging & offering quality education and performing sound research to foster & raise wound care.

About Spectral AI

Spectral AI, Inc. is a Dallas-based predictive AI company that widely explores medical diagnostics to provide expedited & more accurate treatment decisions in wound care. Furthermore, this comprises initial applications consisting of patients with burns. Alongside, this firm is putting efforts into transforming the management of wound care by ‘Seeing the Unknown’ with its DeepView System.

Whereas Spectral AI's DeepView System, which received the grant of the FDA De Novo Classification in May 2026, is a non-invasive, predictive medical device that integrates multispectral imaging with a proprietary AI algorithm to study the healing possible of areas within the burn wounds.

According to Towards Healthcare, the U.S. wound wash market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 339.7 million in 2026 to approximately USD 564.25 million by 2035, representing a compound annual growth rate (CAGR) of 5.8% from 2026 to 2035.Growing instances of diabetic foot ulcers, pressure ulcers, & venous leg ulcers, along with surging focus on mitigation of surgical site infection (SSI), drive the overall market progression. Many leaders are promoting outpatient wound management for diabetic & pressure ulcers, easy-to-use spray formulations & wipes.

Novelty in Products & Developing Smart Sensors Support the Prospective Era

According to Towards Healthcare, the U.S. wound wash market will grow, as researchers are spurring the development of envelopes for next-generation washes to combat drug-resistant bacteria on contact by enhancing tissue regeneration. In addition, the latest wound wash protocols are unifying with smart, biosensor-enabled dressings to assess how well they balance a wound's pH, temperature, & moisture post-wash.